J. Zhang, “MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway”, Cell Mol Biol (Noisy-le-grand), vol. 64, no. 11, pp. 50–57, Aug. 2018.